Motor neuron disease

Motor neuron diseases are rare neurodegenerative disorders characterized by a progressive loss of motor neurons, leading to motor dysfunction and progressive paralysis.

Our missions

  • To conduct epidemiological surveillance of motor neuron diseases

  • To study their link to certain environmental or occupational exposures

  • Informing public authorities and healthcare professionals

Data

Between 2010 and 2021, approximately 2,250 new cases and 1,840 deaths were recorded in France. The incidence of motor neuron diseases (MND) is approximately 3.4 new cases per 100,000 person-years, and the mortality rate is 2.5 deaths per 100,000 person-years.

There was no major change over time in the incidence or mortality of MND during the 2010–2021 period. The slight increase in the crude (unadjusted) indicators disappears after adjustment for age and sex. The absolute number of MND cases is increasing, but this is due to population aging and the growing number of people in the age groups where the disease is most commonly diagnosed.

Crude and age-standardized incidence and mortality rates associated with motor neuron diseases in France since 2010

Taux bruts et standardisés d'incidence et de mortalité en lien avec les maladies du motoneurone en France depuis 2010
SNDS - Public Health France

The incidence of motor neuron diseases rises sharply with age, peaking between the ages of 70 and 79, and then declines thereafter; 35% of new cases occur in people under the age of 65. Across all age groups, the incidence is higher in men than in women.

Incidence and mortality rates (per 100,000 person-years) for motor neuron diseases by age and sex in France for the period 2010–2021

Taux d'incidence et de mortalité (pour 100 000 personnes-années) des maladies du motoneurone selon l'âge et le sexe en France sur la période 2010-2021
SNDS - Public Health France

Regional disparities have been observed, with certain areas showing higher incidence or mortality rates than the national average. Regional,
departmental, and EPCI-level data on motor neuron diseases are available on the Odissé open data platform.

Learn more

enquêtes/études

16 March 2026

Prevalence of motor neuron diseases (including amyotrophic lateral sclerosis) and regional disparities in France. Data from 2010 to 2021